| Course | PAC 610 Psychopharmacology |
|---|---|
| Module | Module 2 |
| Paper type | Concepts paper with case |
| Length | About 1,061 words, 6 pages |
| Format | APA 7 student paper |
| School | Aspen University |
| Program | Psychology and Addiction Studies |
| Updated | October 2026 |
Free sample paper for PAC 610 Module 2
Why the Same Dose Works Differently: Pharmacokinetics, Pharmacodynamics and a Client Who Quit Smoking
Student Name
Psychology and Addiction Studies Program, Aspen University
PAC 610: Psychopharmacology
Instructor Name
Month Day, Year
Why the Same Dose Works Differently: Pharmacokinetics, Pharmacodynamics and a Client Who Quit Smoking
At Ridgeview Recovery Center, the Knoxville program invented for these papers, a counselor named Tasha noticed that Andre, a client in his forties with schizophrenia and a history of cocaine use, was nodding off in group and stumbling on the stairs. Andre had been stable for a year on clozapine. Two months earlier, he had proudly quit smoking. Tasha wondered whether the two were connected. Answering that question requires the two halves of pharmacology, one about the body's work on a medicine and one about the medicine's work on the body.
Two Questions About Every Drug
Pharmacokinetics follows a medicine's journey: its entry into the blood, its spread to tissues, its chemical breakdown and its exit. Pharmacodynamics describes the drug's effects on the body: which targets it binds, what happens when it does and how the size of the effect relates to the amount present. The two together explain why the same dose can produce different effects in different people, or in the same person at different times.
The Body's Handling of a Drug
| Stage | What happens | Practical example |
|---|---|---|
| Absorption | The drug enters the bloodstream, most often from the gut | Some medications are absorbed better with food; others are taken on an empty stomach |
| Distribution | The drug travels through the blood to tissues, including the brain | Drugs that dissolve readily in fat cross into the brain more easily and can linger in fatty tissue |
| Metabolism | Enzymes, mostly in the liver, change the drug, usually into forms easier to remove | Drugs taken by mouth pass through the liver before reaching the rest of the body, which can reduce how much arrives |
| Elimination | The drug and its breakdown products leave, mostly through the kidneys | Kidney disease can let lithium build up to dangerous levels |
Half-Life and Steady State
Half-life means how long the blood level of a drug needs to drop to half its starting value. It shapes how often a drug must be taken and how long it takes to settle. When a person takes a drug regularly, the level rises until intake balances removal, a point called steady state, which takes roughly four or five half-life periods to arrive. Clearing works the same way in reverse: after the last dose, about as many half-life periods pass before the drug is essentially gone. This is why a dose change may take days to show its full effect, and why a drug with a very long half-life can keep acting for a week or more after the last dose.
The Enzymes That Break Drugs Down
Zanger and Schwab (2013) reviewed the cytochrome P450 enzymes, a family of liver enzymes responsible for metabolizing most medications in use. A small number of them, including CYP3A4, CYP2D6, CYP2C19, CYP2C9 and CYP1A2, handle the great majority of drugs. The activity of these enzymes varies widely between people for two broad reasons. First, other substances can change it. Some drugs inhibit an enzyme, slowing the breakdown of other drugs that depend on it and raising their levels. Others induce an enzyme, speeding it up and lowering levels. Chemicals in tobacco smoke are strong inducers of CYP1A2. Second, genes vary. Inherited differences in enzymes such as CYP2D6 and CYP2C19 mean that some people break certain drugs down very slowly, others normally and others unusually fast.
Hicks et al. (2015), writing for the Clinical Pharmacogenetics Implementation Consortium, turned this genetic variation into dosing guidance for selective serotonin reuptake inhibitors. For example, people who are poor metabolizers through CYP2C19 may reach high levels of citalopram, escitalopram or sertraline at standard doses, and the guideline suggests considering a lower starting dose or a different drug; people who are ultrarapid metabolizers may clear these drugs so quickly that a standard dose fails. Genetic testing is not routine for most clients, but the guideline shows that a client who has failed several medications or had unusually strong side effects may not be imagining it.
What the Drug Does: Receptors and Occupancy
Most psychiatric drugs act by binding to receptors or transporters. A full agonist activates a receptor as the natural messenger would. An antagonist binds without activating it, blocking the messenger. A partial agonist activates the receptor only partly, so it can raise activity where the messenger is scarce and limit it where the messenger is abundant; buprenorphine, used in treating opioid use disorder, is a partial agonist at opioid receptors. Affinity describes how tightly a drug binds, and efficacy how strongly it activates the receptor once bound.
Kapur et al. (2000) showed how these ideas link dose to effect. Using brain imaging, they measured the share of dopamine D2 receptors occupied by haloperidol in patients with a first episode of schizophrenia. Clinical response became likely once occupancy exceeded about 65 percent. Raised prolactin, a hormonal side effect, became likely above about 72 percent, and movement side effects above about 78 percent. The window between enough and too much was narrow, which helped explain why higher doses of older antipsychotics often added side effects without adding benefit.
Back to Andre
The concepts explain what Tasha saw. Clozapine is metabolized largely by CYP1A2. While Andre smoked, tobacco smoke kept that enzyme working fast, and his dose had been set to match. When he quit, the enzyme slowed over the following weeks, his clozapine level rose and the drug's sedating effects grew, without any change in his dose. Higher clozapine levels can also raise the risk of more serious effects, including seizures. Tasha does not adjust medication and did not tell Andre to change anything. She told him what she had noticed, praised his quitting and, with his consent, called the program's prescriber the same day. The prescriber checked a blood level and reduced the dose. Tasha also made a note to tell the prescriber if Andre ever started smoking again, since the opposite change would lower his level.
Conclusion
Pharmacokinetics explains why the same dose can produce different blood levels, through absorption, distribution, metabolism and elimination, enzyme induction and inhibition and genetic differences in enzymes such as CYP2D6 and CYP2C19. Pharmacodynamics explains how those levels translate into effects, through receptor binding and occupancy. For counselors, the payoff is practical: knowing enough to notice when something has changed, such as a client quitting smoking, and to bring it to the prescriber quickly.
References
Hicks, J. K., Bishop, J. R., Sangkuhl, K., Müller, D. J., Ji, Y., Leckband, S. G., Leeder, J. S., Graham, R. L., Chiulli, D. L., LLerena, A., Skaar, T. C., Scott, S. A., Stingl, J. C., Klein, T. E., Caudle, K. E., & Gaedigk, A. (2015). Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clinical Pharmacology & Therapeutics, 98(2), 127-134. https://doi.org/10.1002/cpt.147
Kapur, S., Zipursky, R., Jones, C., Remington, G., & Houle, S. (2000). Relationship between dopamine D2 occupancy, clinical response, and side effects: A double-blind PET study of first-episode schizophrenia. American Journal of Psychiatry, 157(4), 514-520. https://doi.org/10.1176/appi.ajp.157.4.514
Zanger, U. M., & Schwab, M. (2013). Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & Therapeutics, 138(1), 103-141. https://doi.org/10.1016/j.pharmthera.2012.12.007
Reading the PAC 610 Module 2 assignment instructions
The second module of PAC 610 typically asks for a paper explaining pharmacokinetics and pharmacodynamics and applying them to practice. Use the Module 2 instructions in your Aspen course as your guide; the clients here are invented. Define both terms precisely. Explain absorption, distribution, metabolism and elimination, with half-life and steady state. Describe the role of metabolizing enzymes and why people differ. Explain receptor binding, agonists, antagonists and partial agonists. Apply the concepts to a realistic client situation. Stay within a counselor's scope: recognize and refer, do not adjust doses. Cite each source in APA 7, including any guideline you rely on. Give numbers, such as occupancy thresholds or half-life rules, only where a source supports them.
How this PAC 610 Module 2 example is built
Two months after quitting cigarettes, a client on clozapine at the composite Knoxville program is sleepy and unsteady at group. The counselor's paper uses a four-row table for the stages of drug handling. Zanger and Schwab's Pharmacology and Therapeutics review explains the cytochrome P450 enzymes, including CYP1A2, which tobacco smoke speeds up. The guideline by Hicks and colleagues in Clinical Pharmacology and Therapeutics shows genotype-based SSRI dosing. Kapur and colleagues' American Journal of Psychiatry PET study links occupancy above about 65 percent to response and higher levels to side effects. The case ends with the counselor contacting the prescriber the same day. A short note on what would happen if the client began smoking again shows the same reasoning run in reverse.
Where the marks sit in the PAC 610 Module 2 rubric
Concepts papers earn credit for accurate definitions, correct mechanisms and an application that shows the concepts matter in practice. This example defines both terms clearly and keeps them distinct. The table covers each stage of drug handling with a practical example. Half-life and steady state are explained with the five half-life rule. The enzyme section explains induction and genetic variation with sources. The occupancy study shows how pharmacodynamics links dose to both benefit and harm. The case applies the concepts correctly and keeps the counselor in scope, recognizing a possible problem and contacting the prescriber rather than advising the client. The pharmacogenetics section avoids overselling testing, noting it is not routine.
PAC 610 Module 2 help: mistakes that cost marks
Pharmacology papers often confuse the two terms or describe metabolism as happening in the stomach. Keep the definitions straight: kinetics is the body acting on the drug, dynamics the drug acting on the body. Check every mechanism. Use concrete examples, such as smoking and enzyme induction, to show why the concepts matter. Explain genetic variation without implying that genetic testing settles every question. Stay within scope; counselors notice and refer. Avoid giving specific doses unless your sources do, and never imply a client should change a dose on their own. If a case involves a real risk, show the counselor acting quickly. Tables help with the four stages, but explain each in prose too, because a list alone does not show that you grasp how one stage feeds the next.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official Aspen University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.
More PAC 610 and Psychology and Addiction Studies sample papers
- PAC 610 Module 1: Neurons, Neurotransmitters and History
- PAC 610 Module 3: Antidepressants
- PAC 610 Module 4: Antipsychotics and Mood Stabilizers
- PAC 610 Module 5: Anxiolytics, Hypnotics and Stimulants
- PAC 610 Module 6: Medications for Substance Use Disorders
- PAC 610 Module 7: Side Effects, Interactions and Adherence
- PAC 610 Module 8: Clinical Applications and Current Issues
- PAC 115 Module 2: Building and Decoding Terms
- PAC 320 Module 8: Children, Adolescents and People in Recovery
- PSY 650 Module 4: Confidentiality and Privacy
- PAC 110 Module 8: Integrating Theory Into Personal Practice
PAC 610 Module 2 questions, answered
What does PAC 610 Module 2 usually ask for?
Aspen's PAC 610 covers pharmacokinetics and pharmacodynamics in this module, so a paper defining and applying both is typical. Check your Module 2 prompt.
What is the difference between pharmacokinetics and pharmacodynamics?
Pharmacokinetics is what the body does to a drug, its absorption, distribution, metabolism and elimination. Pharmacodynamics is what the drug does to the body, through receptors and other targets.
Why does quitting smoking affect some psychiatric medications?
Tobacco smoke speeds up the liver enzyme CYP1A2, so when a person stops smoking, drugs it breaks down, such as clozapine, can build up to higher levels.
Where can I find a free PAC 610 Module 2 sample paper?
Find the full paper above: the four stages of drug handling, enzymes and genetic variation, receptor occupancy and a case on smoking and clozapine.
What is a partial agonist?
A drug that activates a receptor but less fully than the natural messenger, so it can both stimulate and limit activity; buprenorphine is an example at opioid receptors.